Delix Therapeutics

Biotechnology company developing neuropsychiatric drug candidates; closed a $100M Series C in November 2026.

View on the globe

$100MEquity raised in 2025–20262025 — · 2026 $100M · 1 equity round
$100MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 9 Nov 2026 to 9 Nov 2026, $100M equity disclosed. Earlier rounds exist but are not sourced.9 Nov 2026: Series C, $100M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ2Q3Q42027Q2Q3Equity round9 Nov 2026 · Series C · $100M · led by Johnson & Johnson Innovation - JJDC, SV Health Investors' Dementia Discovery FundSeries C · $100M
Funding history: 1 round from 9 Nov 2026 to 9 Nov 2026, $100M equity disclosed. Earlier rounds exist but are not sourced.9 Nov 2026: Series C, $100M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourcedQ3Q42027Q2Q3Equity round9 Nov 2026 · Series C · $100M · led by Johnson & Johnson Innovation - JJDC, SV Health Investors' Dementia Discovery Fund$100M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Delix Therapeutics raised before 9 Nov 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series C
    Amount$100M
    Post-money—
    ✓ Confirmed
    Lead
    Johnson & Johnson Innovation - JJDC, SV Health Investors' Dementia Discovery Fund
    Also
    RA Capital Management, UC Investments, Artis Ventures, OMX Ventures, Dolby Family Ventures, Bail Capital, Adage Capital Management, Hamilton Square Partners Management, Vestal Point Capital, YK Bioventures
    Note
    Valuation not stated. Investor list is partial (release says 'among others'). Release dateline Bedford, Mass. used as HQ (the release boilerplate does not state a headquarters city): recorded as dateline-based. Founding year not stated.
    Sources
  2. Earlier rounds not yet sourced

Investors 12

  • Johnson & Johnson Innovation - JJDC1
  • SV Health Investors' Dementia Discovery Fund1
  • Adage Capital Management
  • Artis Ventures
  • Bail Capital
  • Dolby Family Ventures
  • Hamilton Square Partners Management
  • OMX Ventures
  • RA Capital Management
  • UC Investments
  • Vestal Point Capital
  • YK Bioventures

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Delix Therapeutics and its logo are trademarks of their owners, used here for identification only.